Our Mission & VisionHistory of THETATHETA Staff & CommunityTHETA News ArchiveTHETA Events ArchiveContact Us
Health Modelling and Health EconomicsClinical ResearchHealth Policy and Ethics
Current StudiesCompleted Studies
THETA Quarterly NewsletterReportsPublicationsPresentationsTHETA KT Day, Symposium
and other KT events
Introduction to R for health researchersDecision Modelling Using RHealth Technology Assessment for Decision MakingTHETA RoundsHTA Courses
HTA OrganizationsHTA ConferencesHTA Resources & Tools
Bin Wu ProfileChristelle Moneypenny ProfileMurray Krahn ProfileValeria Rac ProfileLusine Abrahamyan ProfileJoanna Bielecki ProfileSteven Carcone ProfileBrian Chan ProfileSuzanne Chung ProfileIris Fan ProfileOlga Gajic-Veljanoski ProfileGemma Hunting ProfileMildred Lim ProfileKaren Liu ProfileNicholas Mitsakakis ProfilePetros Pechlivanoglou ProfileYelena Petrosyan ProfileBa' Pham ProfileWelson Ryan ProfileYeva Sahakyan ProfileNida Shahid ProfileAleksandra Stanimirovic ProfileGabrielle Van Der Velde ProfileJosephine Wong ProfileWilliam Wong ProfileShawn Xie ProfileMike Paulden ProfileLouise Lemieux-Charles ProfileSarah Bermingham ProfileShabbir Alibhai ProfileAmir Azarpazhooh ProfileAhmed M. Bayoumi ProfileChaim Bell ProfileJoseph Beyene ProfileYvonne Bombard ProfileHeather Boon ProfileAnn-Sylvia Brooker ProfileSuzanne Cadarette ProfileJoseph Cafazzo ProfileWendong Chen ProfilePeter Coyte ProfilePeter Cram ProfileTony Culyer ProfileAllan Detsky ProfileThomas R. Einarson ProfileRobert Fowler ProfileJennifer Gibson ProfilePaul Grootendorst ProfileJeffrey S. Hoch ProfileAudrey Laporte ProfileLouise Lemieux-Charles ProfileLinda D. Mackeigan ProfileMuhammad Mamdani ProfileEleanor Pullenayegum ProfileFiona Miller ProfileNicole Mittmann ProfileGary Naglie ProfileBeate Sander ProfileMonica Parry ProfileJanet Parson ProfileZahava Rosenberg-Yunger ProfileHla Hla (Rosie) Thein ProfileGeorge Tomlinson ProfileWendy Ungar ProfileDavid R. Urbach ProfileHarindra Wijeysundera ProfileAndrew Willan ProfileHolly Witteman ProfileWalter Wodchis ProfileGreg Zaric ProfileMerrick Zwarenstein ProfileSarah Bermingham ProfileSavtaj Brar ProfileKaren E. Bremner ProfileDavid Chartash ProfileMaggie Hong Chen ProfileWarren Chin ProfileKuhan Perampaladas ProfileFarah Farahati ProfileKalyani Baldota ProfileRebecca Hancock-Howard ProfileLuciano Ieraci ProfileAva John-Baptiste ProfileMichele Kohli ProfileYan Yun Liu ProfileMarcio Machado ProfileClaire de Oliveira ProfileOrges Ormanidhi ProfileAndrew Pinto ProfileCharly Piwko ProfileMayvis Rebeira ProfileWilliam Witteman ProfileGloria Woo ProfileMary-Ellen Hogan ProfileNader N. Kabboul ProfileChang-Ho Lee ProfileNatasha Nanwa ProfileAmy Tawfik ProfileTroy Francis ProfileWanrudee Isaranuwatchai ProfileFarah N. Mawani ProfileBeena Vyas ProfileMohammed Alhokail ProfileKuan Liu ProfileMyrtha E. Reyna ProfileTeresa Tsui ProfileRick Maharaj ProfileYasmin Saeed ProfileArlene Nugent ProfileAustin Nam ProfileYeesha Poon ProfileAlex Haines ProfileAysegul Erman ProfileSofia Torres ProfileBeate Sander ProfileLauren Ramsay ProfileEric Nauenberg ProfileRaphael Ximenes Profile
ARCC 2016 CONFERENCECAHSPR CONFERENCE 2016QUALITY INDICATORS FOR TELEHOMECARE STUDY - UPDATESMDM - 16TH BIENNIAL EUROPEAN CONFERENCECLINICAL TRIALS DAY!THETA 'S NEW HOMENEW BRU UNITRnaDx Study is recruitingMedsCheck Study – presented at OPA Annual ConferenceDr. Krahn - JAMA article and a book launchSMDM 2015 - 2ND BIENNIAL ASIA-PACIFIC CONFERENCESMDM 2016 - 38TH ANNUAL NORTH AMERICAN MEETINGSMDM 2016 Lusted Student Prize Winners from THETA communityProfessor Murray Krahn Co-Authors Chapters in "Cost-Effectiveness in Health and Medicine"THETA's Year in ReviewTHETA contributions to 2017 CADTH SymposiumDr. Murray Krahn teaches pharmacoeconomics in EthiopiaNew Study by Dr Murray Krahn and Karen Bremner Makes News at ISPOR and UHNTHETA CONTRIBUTIONS TO 2017 CAHSPR CONFERENCECLINICAL TRIALS DAY!ARCC 2017 CONFERENCETHETA PRESENTS AT 2017 IHEA WORLD CONGRESSSMDM 2017 - 39TH ANNUAL NORTH AMERICAN MEETING
This is the "THETA Rounds" page of the "Welcome to Toronto Health Economics and Technology Assessment Collaborative" guide.
Alternate Page for Screenreader Users
Skip to Page Navigation
Skip to Page Content

Welcome to Toronto Health Economics and Technology Assessment Collaborative  

Last Updated: Sep 20, 2017 URL: http://theta.utoronto.ca/HomePage Print Guide

THETA Rounds Print Page

Upcoming Rounds

THETA Rounds - will resume in September.

Since 2008 THETA has been hosting lecture series THETA Rounds and inviting world experts to address various issues related to Health Technology Assessment, Clinical Research and Health Policy and Ethics fields. From January 2016 onwards THETA Rounds are available in the live webinar format. 

All our sessions are held at the following place and time; unless otherwise stated:

Place: Toronto General Hospital, Eaton Building, 10th Floor, 200 Elizabeth St, Rm 10EB240
Time: 1 - 2 pm

In addition, THETA Rounds ARCHIVE 2008 - 2017 containing recordings of full lectures, can be found at the bottom of the page.


    THETA ROUNDS ARCHIVE (2017 - Present)


    Speaker & Topic

    Aug 04, 2017          

    Health economics, public health, public goods and the circular economy
    Rhiannon Tudor Edwards BSc. Econ, M.A., D.Phil., Hon. MFPH, FLSW Professor of Health Economics and the founding Director of health economics research at Bangor University and is now Co-Director of the Centre for Health Economics and Medicines evaluation (CHEME), Bangor University. Rhiannon is also Director of the Welsh Health Economics Support Service (WHESS, funded by NISCHR).

    Jun 16, 2017          

    Research Possibilities in Central Africa
    Philip Wood, MA FRCS and Nancy Houser Wood, BSc MD,
    recounted their work in Congo and described research needs and collaboration/mentoring opportunities for students of Medical and Nursing Colleges in Christian University in Bunia and Université Shalom de Bunia, Congo. Read more about their 40 years work in Congo in the Toronto Star article Aug. 20, 2012.

    Jun 9, 2017          

    Trends in medical cannabis use in Canada, 2001-2016
    Paul Grootendorst, PhD, Director of the Division of Social and Administrative Pharmacy in the Leslie Dan Faculty of Pharmacy, University of Toronto; Associate professor in the Faculty of Pharmacy, and the School of Public Policy and Governance, University of Toronto, Toronto, Canada; Adjunct associate professor in the Department of Economics, McMaster University in Hamilton, Canada; Associate editor of Health Economics.

    May 19, 2017          

    How can economic evaluation inform cost reduction and disinvestment in the hospital setting?.
    Ava John Baptiste, PhD, Assistant Professor at the Schulich Interfaculty Program in Public Health; health economist in the Centre for Medical Evidence, Decision Integrity and Clinical Impact (MEDICI).

    May 12, 2017          

    The potential of open access tools for health planning and modelling: a case study of the Propensity to Cycle Tool.
    ( http://www.pct.bike/) Robin Lovelace, PhD, University Academic Fellow in Transport and Big Data at the Leeds Institute for Transport Studies (ITS), UK. Short Bio & Abstract
    (due to technical difficulties recording is not available for the first few minutes of the session)

    Apr 21, 2017          

    Value based decision-making from different perspectives: case studies from rheumatoid arthritis.
    (recording will be released upon author's approval)
    Nick Bansback, PhD, CHÉOS Program Head - Decision Sciences; Assistant Professor, School of Population and Public Health, UBC Short Bio

    Mar 24, 2017          

    The promise and pitfalls of Remote Patient Monitoring.
    Heather Ross, BSc, MHSc, MD, FRCPC, FACC, Professor of Medicine at the University of Toronto, Director of the Ted Rogers Centre of Excellence in Heart Function and holder of the Ted Rogers and Family Chair in Heart Function, Affiliate Scientist, Toronto General Research Institute (TGRI). Short Bio

    Mar 10, 2017          

    Policy and Economics Research in Childhood Cancer (PERCC) Centre.
    Sumit Gupta, MD, PhD, FRCPC Oncologist and Clinician Investigator at the Hospital for Sick Children, an Assistant Professor at both the Faculty of Medicine and the Institute for Health Policy, Management and Evaluation at the University of Toronto, and an Adjunct Scientist with the Cancer Research Program at the Institute for Clinical Evaluative Sciences
    Avram Denburg, MD, MSc, FRCPC Staff Phyisican in the Division of Hematology/Oncology at the Hospital for Sick Children, a Staff Pediatrician at North York General Hospital, and a CIHR Doctoral Fellow in Health Policy at the Centre for Health Economics and Policy Analysis, McMaster University
    Susan Horton, PhD CIGI chair in global health economics at University of Waterloo in the Balsillie School of International Affairs. This year she is also Visiting Scholar in Residence at the Centre for Global Child Health at the Hospital for Sick Children, Toronto.

    Feb 10, 2017          

    Value of Information (VOI) and Meta Modelling.
    Hawre Jalal, MD, PhD, Assistant Professor at the Department of Health Policy and Management, University of Pittsburgh.
    Fernando Alarid-Escudero, MS, BSc, PhD
    (candidate) University of Minnesota.    

    Jan 27, 2017          

    Canadian Publicly Funded Prescription Drug Plans, Expenditures and an Overview of Patient Impacts.
    Fiona Clement, PhD,Assistant Prof and Director of HTA Unit, O’Brien Institute of Public Health at University of Calgary.    

    Jan 20, 2017          

    The Future of Health Technology Assessment: The Role of Multisectoral Interventions, Transdisciplinary Approaches and Data-driven Simulation. (due to technical difficulties audio is not available for the first 16 min 16 sec of the session)
    Beate Sander, PhD,Scientist at Public Health Ontario; Assistant Professor at the IHPME, University of Toronto; Adjunct Scientist at ICES; Investigator at THETA.    

    Jan 13, 2017          

    Complex Interventions for Comparative Effectiveness and Health Technology Assessment – real world experience.
    Valeria E. Rac, MD PhD,Associate Program Director and Director, Clinical Research Division, THETA Collaborative; Assistant Professor, IHPME & Faculty of Pharmacy, University of Toronto.    


    THETA Rounds Archive (2016 - 2008)


    Speaker & Topic

    Dec 16, 2016          

    Peter Cram, MD, MBA,Director of Division of General Internal Medicine at Mt. Sinai/UHN Hospitals, Professor of Internal Medicine at the University of Toronto  :  If we mail patients their bone density results, does anything happen? Results from the NIH-funded PAADRN study  (due to technical difficulties audio is available for last 30 min of the session)

    Dec 02, 2016          

    Claire de Oliveira, PhD, an Independent Scientist and Health Economist with the Institute for Mental Health Policy Research at CAMH, and an Assistant Professor in the Institute of Health Policy, Management and Evaluation (IHPME) at the University of Toronto  :  The role of mental health and addiction among high-cost patients. 

    Nov 18, 2016          

    Deb Marshall, PhD Canada Research Chair, Health Services and Systems Research as an Associate Professor at the University of Calgary and Arthur J.E. Child Chair of Rheumatology Outcomes Research in the McCaig Institute of Bone and Joint Health, the Director of Health Technology Assessment at the Alberta Bone and Joint Health Institute, a Senior Scientist of the Arthritis Research Center of Canada, and a member of the Institute of Public Health   :  A Different View: What it Looks Like When you Listen to Patients . (recording will be released upon author's approval)

    Nov 4, 2016          

    Carolina Alba, MD, PhD University Health Network Department of Cardiology Toronto, Canada  :  Prognosis in current heart failure patients. A new approach for predictive model development. 

    Oct 21, 2016          

    Andrea Gershon, MD, M.Sc. Scientist and Research director, Sunnybrook Health Sciences Centre and Institute for Clinical Evaluative Sciences  :  The Ontario COPD Population Health Network 

    Oct 7, 2016          

    Hawre Jalal, MD, PhD, Assistant Professor at the Department of Health Policy and Management, University of Pittsburgh, and at the Public Health Dynamic Laboratory;  :  Examining the Opioid Epidemic from a Public Health Perspective (Audio starts after 2m 34s)

    Sept 23, 2016          

    George Tomlinson, PhD Director of Biostatistics Research Unit, UHN  :  Exploring the use of decision thresholds for ranking treatments in network meta-analysis (Audio starts after 4 min)

    Sept 9, 2016          

    Evaluation of the BresoDx® Portable Monitor for the Diagnosis of Obstructive Sleep Apnea – study results (due to technical difficulties audio is not available for this session)

    Dr. Valeria E. Rac, an Associate Program Director and Director, Clinical Research Division at THETA Collaborative, and an Assistant Professor, at the Institute of Health Policy, Management and Evaluation and the Leslie Dan Faculty of Pharmacy, University of Toronto.
    Dr. Lusine Abrahamyan, a Clinical Epidemiologist at THETA Collaborative, and an Assistant Professor, at the Institute of Health Policy, Management and Evaluation and the Leslie Dan Faculty of Pharmacy, University of Toronto.
    Dr. Petros Pechlivanoglou, Scientist at Child Health Evaluative Sciences, Sick Kids Hospital.
    Evaluation of the BresoDx® Portable Monitor for the Diagnosis of Obstructive Sleep Apnea – study results (due to technical difficulties audio is not available for this session)

    Jun 17, 2016          

    Harindra Wijeysundera, MD, PhD, FRCPC, Scientist, Schulich Heart Research Program, Sunnybrook Research Inst, Asst professor, IHPME and Dept of Medicine, UofT  :  Appropriate Use Criteria in the Diagnosis and Management of Coronary Artery Disease: Insights from a Provincial Registry (Audio good after first 4 min)

    May 20, 2016          

    Mark Sculpher, PhD, Professor of Health Economics and Director of the Programme on Economic Evaluation and Health Technology Assessment University of York, UK 

    Murray Krahn, MD, MSc, FRCPC, Director of THETA, the F. Norman Hughes Chair in Pharmacoeconomics and Social and Administrative Pharmacy Division Head in the Faculty of Pharmacy, Professor at the University of Toronto, and Scientist and Adjunct Scientist at the Toronto General Research Institute and Institute for Clinical Evaluative Sciences 

      CEA should be the primary decision making criterion in decisions about health technology and services (Prof. Mark Sculpher) vs CEA is useful/essential, but only one of several decision criteria (Dr Murray Krahn) 

    May 6, 2016          

    Diarmuid Coughlan, MPharm, MSc (Health Econ), PhD, Cancer Prevention Fellow at Surveillance Research Program, National Cancer Institute, US  :  Medical Costs’ and ‘Financial Toxicity’ of Cancer Care in the USA  (only abstract available)

    Apr 22, 2016          

    Lauren Cipriano, PhD, Assistant Professor in Management Science, Ivey Business School, Western University, London, ON  :  Evaluating patient prioritization schemes for hepatitis C treatment under budget constraints 

    Apr 15, 2016          

    Bruce Y. Lee, MD, MBA, Associate Professor of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD  :  Systems Modeling in Public and Global Health 

    Apr 8, 2016          

    Janel Hanmer, MD, PhD, Assistant Professor of Medicine, University of Pittsburgh, US  :  Construction of a preference-based summary score for the Patient Reported Outcomes Measurement Information System (PROMIS) 

    Mar 18, 2016          

    Tom Trikalinos, PhD, Associate Professor of Health Services, Policy and Practice, Director of Evidence-Based Medicine, Brown University, Rhode Island, US  :  Decision-making under competing interpretations of the evidence: Application in prostate cancer screening  (due to technical difficulties first 10min of the lecture are not available)

    Mar 4, 2016          

    Eva Enns, PhD, Assistant Professor, Health Policy & Management, University of Minnesota, US  :  Identifying Best-fitting Inputs in Multi-target Model Calibration  (due to technical difficulties first 6min of the lecture are not available)

    Feb 19, 2016          

    Gianluca Baio, Msc, PhD, Department of Statistical Sciences at University College London (UK).  :  Value of Information in practice. No, seriously: in practice! 

    Feb 5, 2016          

    David Henry, MB ChB, MRCP, FRCP, Professor of Health Systems Data, co-lead for "Big Data for Health" initiative at the IHPME and Dalla Lana School of Public Health, University of Toronto.  :  Opportunities Created by the Changing Landscape of Health Data 

    Jan 15, 2016          

    Murray Krahn, MD, MSc, FRCPC, Director of THETA, the F. N. Hughes Chair in Pharmacoeconomics and Social and Administrative Pharmacy Division Head, Faculty of Pharmacy, Professor at the University of Toronto, and Scientist and Adjunct Scientist at the Toronto General Research Institute and Institute for Clinical Evaluative Sciences, respectively, active physician General Internal Medicine at the University Health Network, Toronto.  :  Developing a Values Based Framework for Decision Making in Technology Assessment (and Health) 


    Speaker & Topic

    Feb 5, 2016          

    David Henry, MB ChB, MRCP, FRCP, Professor of Health Systems Data, co-lead for "Big Data for Health" initiative at the IHPME and Dalla Lana School of Public Health, University of Toronto.  :  Opportunities Created by the Changing Landscape of Health Data 

    Dec 18, 2015          

    Feng Xie, BSc, MSc, PhD, Associate Professor, Dept of Clinical Epidemiology & Biostatistics; Acting Assistant Dean, Faculty of Health Sciences, McMaster University  :  Health utility for coverage decision making: imagination, prediction, or deception? 

    Dec 4, 2015          

    Janet Parson, PhD, Scientist, Li Ka Shing Knowledge Institute; Assistant Professor, Dept of Physical Therapy, and CQ Fellow Dalla Lana School of Public Health, University of Toronto  :  On being an outlier: Participatory arts-based research methods in the service of practice and policy 

    Nov 20, 2015          

    Andrea Tricco, PhD, Scientist, Li Ka Shing Knowledge Institute; Assistant Professor, Dalla Lana School of Public Health, University of Toronto  :  Does it matter: timeliness or accuracy of results? The choice of rapid reviews or systematic reviews to inform decision-making. 

    Nov 6, 2015          

    Noemi Kreif, PhD, Research Fellow in Health Economics , London school of Hygiene and Tropical Medicine. Estimating the causal effects of longitudinal treatment regimes: an application in critical care (the recording will be available at the later date)

    Oct 23, 2015          

    Beate Sander, PhD, Scientist, Public Health Ontario, Assistant Professor, IHPME, University of Toronto, Adjunct Scientist, ICES  :  Humans, Mosquitoes, Birds & The Environment: Evaluating West Nile Virus Mitigation Strategies  

    Oct 9, 2015          

    Michael Hillmer, PhD, Director - Planning, Research and Analysis Branch, OMHLTC, Assistant Professor , Institute of Health Policy, Management and Evaluation, U of Toronto  :  Health Services Research and Policy Making in Ontario  

    Sep 11, 2015          

    Iben Fasterholdt, PhD student / HTA consultant at University of Southern Denmark (SDU) and Odense University Hospital (OUH), Denmark  :  Telemedicine in DK/Europe – are we evaluating early enough?  

    May – Sept, 2013

    Summer Break

    May 1, 2015          

    Mike Kattan, PhD, Cleveland Clinic  :  Statistical Prediction Models and Medical Decision Making  

    Apr 10, 2015          

    David Paltiel, PhD, Yale School of Public Health  :  Reducing Sexual Violence by Increasing the Supply of Toilets in Khayelitsha, South Africa  

    Mar 20, 2015          

    Robin Hayeems, ScM, PhD, Scientist-track Investigator at Sick Kids Hospital  :  Whole genome sequencing in pediatrics: current ethical controversies  

    Mar 6, 2015          

    J. Jaime Caro, MDCM, FRCPC, FACP, Chief Scientist at Evidera, adjunct Professor at McGill University  :  Rolling the DICE: can we do better than Markov, DES, and Microsimulation?  (Note: due to technical issues initial half of the lecture's audio is unclear)

    Feb 20, 2015          

    Natasha Stout, PhD, Assistant Professor, Population Medicine, Harvard Medical School  :  Screening breast MRI: Emerging trends in community use.  

    Feb 6, 2015          

    Wendy Ungar MSc, PhD Senior Scientist at Sick Kids Hospital  :  Economic Evaluation and Child Health: Will the growth spurt be sustained?  

    Jan 23, 2015          

    William Wong, PhD, THETA and Assistant Professor at the Faculty of Pharmacy, University of Toronto  :  Cost-Effectiveness of Screening for Hepatitis C in Canada  

    Jan 9, 2015          

    Eleanor Pullenayegum MA, PhD, Biostatistics, University of Toronto  :  Statistical analysis of matched longitudinal cost data.  


    Speaker & Topic

    Dec 12, 2014          

    Jeffrey S. Hoch, MA, PhD, Li Ka Shing Knowledge Institute Real world cost-effectiveness analysis: The case of a cancer drug.  

    Nov 21, 2014          

    Catherine Demers, MD, MSc, FRCPC, McMaster University, Department of Medicine, Division of Cardiology Heart Failure Self-Care and Cognition: Improving Outcomes.  

    Nov 7, 2014          

    David Feeny, PhD, McMaster University, Department of Economics A Brief History of the Health Utilities Index (HUI).  

    Oct 17, 2014          

    Fiona Miller, PhD University of Toronto, Institute of Health Policy, Management and Evaluation Integrating ethics & social values into HTA: The case of uterine fibroids.  

    Oct 3, 2014          

    Ava John Baptiste, PhD Western University, The Western Centre for Public Health and Family Medicine Is less more? A systematic review of disinvestment trials.  

    Sep 25, 2014          

    Prof Anirban Basu University of Washington, School of Public Health, Department of Health Services Long-Term Health Returns to Alternative Schooling System: the Roles of Selection and Heterogeneity  (Lecture starts at 4:20 min into the recording)

    May 30, 2014          

    Prof Maarten J Postma (University of Groningen)Role of Health Economics and its Specificities in the Dutch Reimbursement of Vaccines  

    May 9, 2014          

    Louise B. Russell, (Ph.D., Economics, Harvard) is Distinguished Professor at the Institute and in the Department of Economics, Rutgers UniversityMaking Public Decisions about Health: Cost-Effectiveness and Cost-Benefit Analysis   (Lecture starts 7:55 min into the recording)

    Apr 25, 2014          

    Dr. Ahmed Bayoumi, MD, MSc, FRCPCSupervised Injection Facilities in Toronto and Ottawa: Evidence, Models, and Policies  

    Apr 11, 2014          

    Fernando Alarid, MS Economics, BSc Biomedical EngineeringHealth care decision making in Mexico: The role of HTA and economic evaluation  

    Mar 21, 2014          

    Valeria E. Rac, MD, PhDEvaluation of the Complex Interventions - THETA's experience  

    Mar 7, 2014          

    Dr. David MoherIs society getting a good return on its funding investment in medical research? Examining the quality of reports of medical research and strategies to maximize the outputs of the investments  

    Feb 14, 2014          

    Shannon Cope, MScNetwork meta-analysis of survival outcomes

    Jan 31, 2014          

    Ivar Kristiansen, PhDPrevention of cardiovascular disease – should we inform patients about reduced risk or increased longevity? 

    Jan 17, 2014          

    Ester Moher, PhDThe perilous promise of privacy: Health disclosures in a brave new world 


    Speaker & Topic

    Dec 13, 2013          

    Courtney Davis, PhDMapping recent and current trends in pharmaceutical regulation: implications for innovation, safety and the cost-effective use of new medicines 

    Nov 29, 2013          

    Stuart Hogarth, PhDFrom Papanicolaou to Papilloma: the corporatisation of cancer screening innovation  

    Nov 8, 2013          

    Heather Taffet Gold, PhDAdoption and cost effectiveness of breast cancer radiotherapy technologies: Quantitative and qualitative evaluation 

    Oct 4, 2013          

    Lisa Prosser, Ph.D.Comparative Effectiveness and Child Health 

    Sep 20, 2013          

    Petros Pechlivanoglou MSc, PhDAn introduction to network meta-analysis (methods and applications) and why we should care about it. 

    Sep 6, 2013          

    Ba' Pham, MSc, PhD(c): Developing methods for the estimation of the cost-effectiveness threshold for cost-effectiveness analysis 

    May – Sept, 2013

    Summer Break

    May 31, 2013        

    Andy WillanValue and uncertainty in pricing new health care interventions 

    May 17, 2013        

    Scott GrosseChallenges in Assessing the Economic Value of Treatments for Rare Disorders: Prophylaxis in Hemophilia

    May 3, 2013          

    Jeremy Goldhaber-FiebertTuberculosis, Drug Resistance, and The Potential Effectiveness of Multiple Types of Interventions: Mathematical Modeling for Policy Analyses

    April 19, 2013       

    Kamran Khan: Evaluating the Immigration Screening Process for the Prevention and Early Detection of Active Tuberculosis

    April 5, 2013          

    Pascale Lehoux: The Interactions Between Business Models and Health Technology Design: A Comparative Analysis of Three Academic Spin-Offs

    March 22, 2013     

    Mike PauldenAdvancing the methods of cost-effectiveness analysis: why it's time to move on from ICERs and thresholds

    March 8, 2013      

    Hai NguyenOntario's generic drug pricing policy

    February 22, 2013 

    Craig Mitton: Priority setting in health care: lessons learned and next steps

    February 8, 2013   

    THETA Rounds are CANCELLED due to inclement weather

    January 25, 2013   

    Onil Battacharrya, MD, PhD and Michael Schull, MD, MSc, FRCPCBRIDGES: creation of an incubator for health system integration and evaluation.

    January 17, 2013   

    Special THETA Rounds presentation: Dr. Stirling Bryan: Are we suffering an addiction to adoption in health economics?

    January 11, 2013   

    Walter Wodchis: Person-centered Costing Using Administrative Data

    December 14, 2012  - Ba' Pham, MSc, Decision Modeler: Calibration of decision models – A non-technical overview of a conceptual framework and literature review

    December 7, 2012      - Laurie Lambert: Field evaluations of cardiac care: lessons learned by the tertiary cardiology unit of illnesses.

    November 23, 2012    - Michael Iskedjian: Determining the monetary value of a QALY: From which perspective and whose preference?

    November 16, 2012    - Antoine Boivin, MD, PhD: Involving the public in healthcare priority setting: moving from rhetoric to action(Resources only)

    November 2, 2012, 1pm - Sarah Bermingham, BSc, MSc: A NICE perspective

    October 5, 2012, 1 pm -  Muhammad Mamdani, PharmD, MA, MPH: Bridging Drug Policy and Research: The Ontario Drug Policy Research Network

    September 21, 2012, 1pm - Dr. Joseph Cafazzo, PhD PEng: Patient, Health Thyself: Self-care facilitated by mHealth

    September 7, 2012, 1pm - Dr. Joel Lexchin: Evergreening: Patents and Money

    June 1, 2012, 12pm - Petros Pechlivanoglou: Intergrating network meta-analysis and decision analytic modeling in a common framework

    May 4, 2012, 12pm - Rumona Dickson: HTA and the establishment of health policy in the UK: working in the NICE appraisal process

    April 27, 2012, 12pm - Tina Shih: Important advances in cost-effectiveness analysis

    April 13, 2012, 12pm - Christopher S. Hollenbeak: The implications of cancer survivorship for spousal employment

    March 23, 2012, 12pm - Open Debate: Open debate: Cost-effectiveness analysis is not useful in the real world

    March 9, 2012, 12pm - Rosie Thein and William Wong: Model-based evaluation of prevention and treatment interventions for hepatitis C

    March 2, 2012, 12pm - Dante Morra: The Innovated A-Fib Project - Implementing Disease Specific Value Based Care

    February 24, 2012, 12pm - Mireille Goetghebeur: What MCDA EVIDEM can bring to the HTA table.

    February 10, 2012, 12pm - Farzad Ali: Early payer engagement by industry: Can we afford not to do it?

    January 27, 2012, 12pm - Mona Sabharwal: The pan-Canadian Oncology Drug Review: facts, fallacies and frequently asked questions.

    December 16, 2011, 12pm - Karen Born and Andreas Laupacis: Promoting health policy literacy via the social web. The case ofwww.healthydebate.ca

    December 2, 2011, 12pm - Janet Martin: Do you know Know4Go? Full contact HTA in the real world

    November 18, 2011, 12pm - Dr. Peter Anglin: Offering cancer patients who can afford it access to high-priced new drugs the public system does not fund

    November 4, 2011, 12pm - David Naimark: PRO: The half-cycle correction explained: two alternative pedagogical approaches. CON: The Half-Cycle Correction: Banish Rather Than Explain It

    October 7, 2011, 12pm - Karen Lee: Recent Issues in Formulary Submissions

    September 23, 2011, 12pm - Peter Neumann: Cost-Effectiveness Analysis in U.S. Health Care: Trends, Myths, and Future Directions

    September 9, 2011, 12pm - William Witteman: Demythologizing the high costs of pharmaceutical research

    August 12, 2011, 12pm - Sarah Garner: A NICE update

    May 20, 2011, 12pm - Claire de Oliveira: Measuring the ROI on Cardiovascular Disease Research for the Institute of Circulatory and Respiratory Research at CIHR

    May 6, 2011, 12pm - Li Ka Shing Knowledge Institute Presents Stephen Duckett: "Will ageing bankrupt the health system? If not, why not?"

    April 8, 2011, 12pm - Don Husereau: The Relevance of Ignorance and Other Future Challenges for HTA

    March 11, 2011, 12pm - Irfan Dhalla: Perspectives on NICE's recommendations to use technologies only in research

    February 11, 2011, 12pm - Mike Paulden: Investment and disinvestment of health technologies: the need for two cost-effectiveness thresholds

    January 28, 2011, 12pm - Dr. Stirling Bryan: Outcome-based Performance Metrics in Health Care: Has Their Time Come?

    January 14, 2011, 12pm - David Shum: Industry perspectives of HTA

    December 17, 2010, 12pm - Thérèse Stukel: In Healthcare, Is More Always Better?

    December 3, 2010, 12pm - Mike Paulden: The NICE cost-effectiveness threshold: what it is and what that means

    November 12, 2010, 12pm - Iris Lansdorp-Vogelaar: MISCAN-Colon: a microsimulation model to estimate the effects of colorectal cancer screening on population health

    November 5, 2010, 12pm - David Meltzer: The Importance of Self-selection in Medical Cost-effectiveness Analysis

    October 22, 2010, 12pm - Anirban Basu: Estimating lifetime or episode-of-illness costs under censoring

    October 20, 2010, 12pm - Maurice McGregor: How to Get the Most Out of HTA - SPECIAL WEDNESDAY ROUNDS

    October 8, 2010, 12pm - David Fisman: Modelling an influenza pandemic: A guide for the perplexed

    September 17, 2010, 12pm - Gerald Evans: Reality Bites: Tales from the CED

    September 10, 2010, 12pm - Guillermo Sandoval: The Alternate Level of Care (ALC) Challenge: Potential areas for cost-effectiveness analysis

    May 28, 2010, 12pm - THETA Retreat (No Rounds)

    May 21, 2010, 12pm - Martin Brown: Recent Developments in Cancer Comparative Effectiveness Research in the United States: Opportunities and Challenges

    April 30, 2010, 12pm - Eyal Cohen: Cost-effectiveness of Competing Strategies for the Treatment of Pediatric Empyema

    April 16, 2010, 12pm - Stephanie Van Bebber: The Decision Maker's Toolbox: Fitting A Round Peg Into A Square Hole?

    March 12, 2010, 12pm - Marc Brisson: Impact of structural uncertainty on predictions of HPV vaccine effectiveness: A comparative model-based analysis

    March 5, 2010, 12pm - Konrad Fassbender: Economics of Palliative and End of Life Care

    February 19, 2010, 12pm - Colin Vicente: How pharmaceutical pricing decisions are made - a local industry perspective

    February 12, 2010, 12pm - Paul Grootendorst: Instrumental Variables Estimation

    February 5, 2010, 12pm - Deborah Marshall: HSR and HTA: Bosom Buddies in the economic evaluation of personalized breast cancer drugs?

    January 29, 2010, 12pm - Mark Sculpher: Reflecting uncertainty in cost-effectiveness: moving beyond technical analyses to inform policy questions

    January 29, 2010, 12pm - Mark Sculpher: Reflecting uncertainty in cost-effectiveness: moving beyond technical analyses to inform policy questions

    January 22, 2010, 12pm - Hugh Walker: The "Best Use" of Cancer Drugs When Financial and Professional Resources are Limited

    January 15, 2010, 12pm - Gloria Woo: Evolving paradigms in the treatment of hepatitis B

    January 8, 2010, 12pm - Nicole Mittmann: Through the Looking Glass: Economics and Cancer

    December 18, 2009, 12pm - Warren Chin: Involving Stakeholders in Healthcare Decisions

    December 4, 2009, 12pm - Rebecca Hancock: An economic evaluation of teratology information services

    November 20, 2009, 12pm - Parneet Cheema: Reimbursement of New Cancer Therapeutics: A Global Perspective

    November 13, 2009, 12pm - Sara Khor: Ontario's formulary committee: how recommendations are made

    October 23, 2009, 12pm - Jean Yong: Representing Uncertainty: The Role of Cost-Effectiveness Acceptability Curves

    October 9, 2009, 12pm - Katia Noyes: Certainly uncertain: economic evaluations of healthcare interventions in the US

    September 25, 2009, 12pm - Wendy Ungar: From Beijing to Xin Hua and back again. A Canadian's view of Chinese health care reform

    September 11, 2009, 12pm - Michael Carter: Can Healthcare Engineering Models Influence Policy Decisions?

    June 12, 2009, 12pm - Susan Griffin: Dangerous Omissions: The Consequences of Ignoring Decision Uncertainty

    June 11, 2009, 12pm - Andrew Briggs: Statistical Methods for Health Economic Evaluation: Current trends and future directions

    May 29, 2009, 12pm - Mark Roberts: Virtual Clinical Trials: Gaining Biological Insights Through Mathematical Models

    May 15, 2009, 12pm - Ava John-Baptiste: Cost-effectiveness acceptability curves - facts, fallacies and frequently asked questions

    May 8, 2009, 12pm - Matthew Kowgier: Cost-effectiveness analysis of a multinational RCT

    May 1, 2009, 12pm - Michael Drummond: Is the QALY in Terminal Care?

    April 17, 2009, 12pm - Marcio Machado: Heterogeneity in data combination: the good, the bad, and the ugly

    April 3, 2009, 12pm - Luciano Ieraci: Cost estimation using regression, re-transformation and smoothing

    March 18, 2009, 12pm - Karl Claxton: On the eve of the mother of all battles: prospects for NICE

    March 6, 2009, 12pm - Angela Rocchi: The Role of Economic Evidence in Canadian Oncology Reimbursement Decision-Making: To Lambda and Beyond

    February 20, 2009, 12pm - William Witteman: Potential of electronic personal health records

    February 6, 2009, 12pm - Merrick Zwarenstein: Pragmatic trials: back to the future for the randomised clinical trial

    January 23, 2009, 12pm - Marcio Machado: Expected Value of Perfect Information: An Empirical Example of Reducing Decision Uncertainty by Conducting Additional Research

    January 9, 2009, 12pm - Greg Zaric: The cost-effectiveness of Vancouver's supervised injection facility

    December 12, 2008, 12pm - Wendy Ungar and Vania Costa: Health Technology Assessment of caspofungin in the empiric treatment of children with febrile neutropenia

    November 28, 2008, 12pm - Fiona Miller: The Relationship Between Academic Technology Transfer for Health Innovation and Health Technology Assessment

    November 14, 2008, 12pm - Rinku Sutradhar: Clustered Progressive Multi-State Processes Under Incomplete Observation: Application to Joint Damage in Psoriatic Arthritis

    October 31, 2008, 12pm - Ba' Pham: Calibration Analysis of Decision Analytic Models for Economic Evaluation

    October 17, 2008, 12pm - Eleanor Pullenayegum: Inferring causal relationships from observational data: Are marginal structural models the solutions?

    September 19, 2008, 12pm - Marcio Machado: Transferability of economic evaluations across jurisdictions: ISPOR good research practices task force report

    September 5, 2008, 12pm - Robert Fowler: Challenges in the economic evaluation of the E-PROJECT study

    July 11, 2008, 12pm - Farah Farahati: Recent Developments in Decision-Analytic Modelling for Economic Evaluation

    • Leslie Dan Faculty of Pharmacy at the University of Toronto
    • Institute of Health Policy, Management and Evaluation (IHPME)
    • UHN - Toronto General Hospital

    Loading  Loading...